FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...